Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx Benefit Cost To Be Re-Estimated In President’s ’06 Budget

This article was originally published in The Pink Sheet Daily

Executive Summary

The final regulations will “keep drug prices down” but provide “more use of drugs,” CMS Administrator McClellan says. The Centers for Medicare & Medicaid Services is "on track" to deliver the prescription drug benefit on schedule, he says.

You may also be interested in...



Leavitt Backs Market Approach For Medicare Rx

HHS Secretary nominee Michael Leavitt affirmed his commitment to free market principles in the Medicare drug benefit while appearing before a Senate committee Jan. 18

Sen. Kennedy Assails Bush On Medicare Costs, Accuses White House Of “Conspiracy”

Massachusetts Democrat questions plausibility of White House claim that President Bush was unaware of higher cost projection before December. Kennedy identifies actuarial dispute as part of a pattern of deception.

Barr’s Expanded Thalidomide ANDA Could Increase Likelihood Of A Marketed Generic

Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.

Topics

UsernamePublicRestriction

Register

OM004674

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel